InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-6.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Skynner Michael, Chief Technology Officer. Officer active across 1 company, notably BICYCLE THERAPEUTICS plc. Cumulatively, 14 filings have been published. Split: 0 buy · 9 sells. Total volume traded: €101k. History available since 3 January 2022. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
1,859 shares@ US$4.270.0027% mcap6.9% of flowOrdinary SharesSEC:0001776582-26-000006:0
532 shares@ US$4.310.0008% mcap2.0% of flowOrdinary SharesSEC:0001776582-26-000006:1
814 shares@ US$8.026.5% of flowOrdinary SharesSEC:0001415889-25-010244:0
35,000 shares0Ordinary SharesSEC:0001415889-25-000923:0
972 shares@ US$22.2621.4% of flowOrdinary SharesSEC:0001415889-24-024770:0
967 shares@ US$19.6419.2% of flowOrdinary SharesSEC:0001415889-24-019388:0
955 shares@ US$23.8122.9% of flowOrdinary SharesSEC:0001415889-24-010417:0
28,000 shares0Ordinary SharesSEC:0001209191-24-000876:0
442 shares@ US$20.009.2% of flowOrdinary SharesSEC:0001209191-23-052248:0
451 shares@ US$25.1011.3% of flowOrdinary SharesSEC:0001209191-23-041574:0
447 shares@ US$21.119.4% of flowOrdinary SharesSEC:0001209191-23-023350:0
17,500 shares0Ordinary SharesSEC:0001209191-23-002198:0
15,000 shares0Ordinary SharesSEC:0001209191-22-001823
15,000 shares0Ordinary SharesSEC:0001209191-22-001823:0
14 of 14 declarations
About Skynner Michael
Michael Skynner serves as the Chief Technology Officer at Bicycle Therapeutics plc. In this role, he is responsible for the company's technological direction, ensuring that innovations support strategic objectives. His expertise in biotechnology and ability to lead technical teams are essential for the development of new products. He plays a key role in the continuous improvement of the company's systems and processes.
